Harmony Biosciences Holdings, Inc. Common Stock
HRMY Real Time Price USDRecent trades of HRMY by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by HRMY's directors and management
Government lobbying spending instances
-
$150,000 Oct 21, 2024 Issue: Pharmacy
-
$150,000 Jul 22, 2024 Issue: Pharmacy Medicare/Medicaid
-
$170,000 Apr 17, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$50,000 Apr 08, 2024 Issue: Health Issues
-
$30,000 Jan 19, 2024 Issue: Health Issues
-
$250,000 Oct 18, 2023 Issue: Pharmacy Health Issues
-
$250,000 Jul 19, 2023 Issue: Medicare/Medicaid Health Issues
-
$250,000 Apr 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$250,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues
-
$250,000 Oct 19, 2022 Issue: Health Issues
-
$250,000 Jul 20, 2022 Issue: Health Issues
-
$250,000 Apr 19, 2022 Issue: Health Issues
-
$250,000 Jan 19, 2022 Issue: Health Issues
-
$250,000 Oct 18, 2021 Issue: Health Issues
-
$250,000 Jul 19, 2021 Issue: Health Issues
-
$230,000 Apr 20, 2021 Issue: Health Issues
-
$140,000 Jan 20, 2021 Issue: Health Issues
-
$140,000 Oct 19, 2020 Issue: Health Issues
-
$140,000 Jul 20, 2020 Issue: Health Issues
-
$160,000 Apr 13, 2020 Issue: Health Issues
-
$160,000 Jan 20, 2020 Issue: Health Issues
-
$160,000 Oct 21, 2019 Issue: Health Issues
-
$160,000 Jul 16, 2019 Issue: Health Issues
-
$160,000 Apr 22, 2019 Issue: Health Issues
-
$80,000 Jan 20, 2019 Issue: Health Issues
-
$80,000 Oct 21, 2018 Issue: Health Issues
-
$30,000 Jul 19, 2018 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Portable substance container with applicator Feb. 18, 2020
-
Patent Title: Portable container and method of manufacturing the same Mar. 06, 2018
Federal grants, loans, and purchases
- $5,085 2024-10-30 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-10-29 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-09-19 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-09-19 00:00:00 Agency: Department of Veterans Affairs
- $5,085 2024-08-26 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-08-23 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-07-22 00:00:00 Agency: Department of Veterans Affairs
- $30,511 2024-07-03 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-06-25 00:00:00 Agency: Department of Veterans Affairs
- $711,900 2024-05-28 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-05-22 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-04-22 00:00:00 Agency: Department of Veterans Affairs
- $50,850 2024-04-02 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-03-27 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-03-12 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-02-27 00:00:00 Agency: Department of Veterans Affairs
- $61,021 2024-02-22 00:00:00 Agency: Department of Veterans Affairs
- $549,193 2024-02-15 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-01-26 00:00:00 Agency: Department of Veterans Affairs
- $10,170 2024-01-26 00:00:00 Agency: Department of Veterans Affairs
- $50,850 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $20,340 2024-01-08 00:00:00 Agency: Department of Veterans Affairs
- $101,700 2024-01-08 00:00:00 Agency: Department of Veterans Affairs
- $27,832 2023-08-02 00:00:00 Agency: Department of Veterans Affairs
Estimated quarterly amount awarded from public contracts
Number of mentions of HRMY in WallStreetBets Daily Discussion
Recent insights relating to HRMY
Recent picks made for HRMY stock on CNBC
ETFs with the largest estimated holdings in HRMY
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HRMY Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.